1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Hand Dermatitis Global Clinical Trials Review, H2, 2015

Hand Dermatitis Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 73 pages

Hand Dermatitis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hand Dermatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hand Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hand Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hand Dermatitis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hand Dermatitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 17
Clinical Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Hand Dermatitis 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Hand Dermatitis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Basilea Pharmaceutica AG 27
Clinical Trial Overview of Basilea Pharmaceutica AG 27
GlaxoSmithKline Plc 28
Clinical Trial Overview of GlaxoSmithKline Plc 28
Omega Pharma NV 29
Clinical Trial Overview of Omega Pharma NV 29
Nuvo Research Inc. 30
Clinical Trial Overview of Nuvo Research Inc. 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
Innovaderm Research Inc. 32
Clinical Trial Overview of Innovaderm Research Inc. 32
HENKAN Pharmaceutical Co., Ltd. 33
Clinical Trial Overview of HENKAN Pharmaceutical Co., Ltd. 33
DermResearch, Inc. 34
Clinical Trial Overview of DermResearch, Inc. 34
Bayer AG 35
Clinical Trial Overview of Bayer AG 35
Astion Pharma A/S (Inactive) 36
Clinical Trial Overview of Astion Pharma A/S (Inactive) 36
Clinical Trial Overview of Top Institutes / Government 37
Cincinnati Children's Hospital Medical Center 37
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 37
Shahid Sadoughi University of Medical Sciences and Health Services 38
Clinical Trial Overview of Shahid Sadoughi University of Medical Sciences and Health Services 38
Technische Universitat Dresden 39
Clinical Trial Overview of Technische Universitat Dresden 39
Tokyo Medical and Dental University 40
Clinical Trial Overview of Tokyo Medical and Dental University 40
Five Key Clinical Profiles 41
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables
Hand Dermatitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hand Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hand Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Hand Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hand Dermatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hand Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Hand Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Hand Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Hand Dermatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Hand Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Hand Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Hand Dermatitis Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Hand Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Hand Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Hand Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Hand Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Hand Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2015* 27
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 28
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Omega Pharma NV, 2015* 29
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research Inc., 2015* 30
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 31
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2015* 32
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by HENKAN Pharmaceutical Co., Ltd., 2015* 33
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DermResearch, Inc., 2015* 34
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 35
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astion Pharma A/S (Inactive), 2015* 36
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015* 37
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Sadoughi University of Medical Sciences and Health Services, 2015* 38
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Technische Universitat Dresden, 2015* 39
Hand Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2015* 40

List of Figures
Hand Dermatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hand Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hand Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Hand Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hand Dermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Hand Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Hand Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Hand Dermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Hand Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Hand Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Hand Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Hand Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Hand Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Hand Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Hand Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Analgesic Market in the UK

  • November 2016
    10 pages
  • Analgesic  

  • United Kingdom  

View report >

Related Market Segments :

Therapy
Clinical Trial
Dermatological Condition

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.